Key Insights

Highlights

Treatment Research

1 treatments under study, led by Cup

Research Leaders

5 sponsors active, led by University of California, San Francisco

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Cup1

Active Sponsors

  • University of California, San Francisco1
  • Restore Health1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
  • Korle-Bu Teaching Hospital, Accra, Ghana1
  • Gynocare Women's and Fistula Hospital, Eldorat, Kenya1

Top Investigators

Related Conditions

  • Fistula1
  • Fistula Urinary1
  • Obstetric Fistula1

Activity Timeline